Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Hudson

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Frontline Gastroenterology|April 14, 2023
Real-world evidence of long-term survival and healthcare resource use in patients with hepatic encephalopathy receiving rifaximin-α treatment: a retrospective observational extension study with long-term follow-up (IMPRESS II)Richard J Aspinall, Mark Hudson, Stephen D Ryder, et al.
The American Journal of Clinical Nutrition|June 20, 2014
Folic acid handling by the human gut: implications for food fortification and supplementationImran Patanwala, Maria J King, David A Barrett, et al.
Journal of Applied Research in Intellectual Disabilities : JARID|February 13, 2020
Standardizing the assessment of emotional development in adults with intellectual and developmental disabilityTanja Sappok, Anton Došen, Sabine Zepperitz, et al.
Journal of Hepatology|August 28, 2013
Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary teamJessica Dyson, Bryan Jaques, Dipankar Chattopadyhay, et al.
Nursing in Critical Care|March 30, 2026
Key Insights From the International ICU Diary Conference 2025Peter Nydahl, Bev Ewens, Anne-Sophie Debue, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 8, 2016
The impact on hospital resource utilisation of treatment of hepatic encephalopathy with rifaximin-αJames G Orr, Craig J Currie, Ellen Berni, et al.
Frontline Gastroenterology|October 26, 2017
The impact of rifaximin-α on the hospital resource use associated with the management of patients with hepatic encephalopathy: a retrospective observational study (IMPRESS)Mark Hudson, Amr Radwan, Paola Di Maggio, et al.
Gut|November 11, 2017
Guidelines on the management of abnormal liver blood testsPhilip N Newsome, Rob Cramb, Suzanne M Davison, et al.
Lancet (London, England)|December 1, 2014
Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitisRoger Williams, Richard Aspinall, Mark Bellis, et al.
Communications Biology|January 20, 2026
HCN channels reveal conserved and divergent physiology in supragranular pyramidal neurons in primate speciesCristina Radaelli, Matthew Schmitz, Xiao-Ping Liu, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Frontline Gastroenterology|April 14, 2023
Real-world evidence of long-term survival and healthcare resource use in patients with hepatic encephalopathy receiving rifaximin-α treatment: a retrospective observational extension study with long-term follow-up (IMPRESS II)Richard J Aspinall, Mark Hudson, Stephen D Ryder, et al.
The American Journal of Clinical Nutrition|June 20, 2014
Folic acid handling by the human gut: implications for food fortification and supplementationImran Patanwala, Maria J King, David A Barrett, et al.
Journal of Applied Research in Intellectual Disabilities : JARID|February 13, 2020
Standardizing the assessment of emotional development in adults with intellectual and developmental disabilityTanja Sappok, Anton Došen, Sabine Zepperitz, et al.
Journal of Hepatology|August 28, 2013
Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary teamJessica Dyson, Bryan Jaques, Dipankar Chattopadyhay, et al.
Nursing in Critical Care|March 30, 2026
Key Insights From the International ICU Diary Conference 2025Peter Nydahl, Bev Ewens, Anne-Sophie Debue, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 8, 2016
The impact on hospital resource utilisation of treatment of hepatic encephalopathy with rifaximin-αJames G Orr, Craig J Currie, Ellen Berni, et al.
Frontline Gastroenterology|October 26, 2017
The impact of rifaximin-α on the hospital resource use associated with the management of patients with hepatic encephalopathy: a retrospective observational study (IMPRESS)Mark Hudson, Amr Radwan, Paola Di Maggio, et al.
Gut|November 11, 2017
Guidelines on the management of abnormal liver blood testsPhilip N Newsome, Rob Cramb, Suzanne M Davison, et al.
Lancet (London, England)|December 1, 2014
Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitisRoger Williams, Richard Aspinall, Mark Bellis, et al.
Communications Biology|January 20, 2026
HCN channels reveal conserved and divergent physiology in supragranular pyramidal neurons in primate speciesCristina Radaelli, Matthew Schmitz, Xiao-Ping Liu, et al.
Pageof 9